Vermillion is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women. Co. concentrates its development of diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer. Co.'s primary product, OVA1, is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery. Co.'s ASPiRA LABS engages in applying biomarker-based technologies to address needs in the management of gynecologic cancers and disease.

VRML — Key Stats (updated Friday, June 12, 10:19 AM)

Name:  Aspira Womens Health Inc Website:  www.vermillion.com Sector:  Medical Instruments & Supplies

VRML — News

Featured Slideshows

Top Ten Highest Yielding Preferred Stocks Feel-Good Income: Socially Responsible Preferreds Dividend Channel's 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Safer than S.A.F.E: Preferreds of Dividend Channel's S.A.F.E. Dividend Stocks Recent Preferred Stock Offerings Preferred Stocks of Dow Components Preferred Stocks of S&P 500 Components Preferred Stocks By Industry Preferred Stocks Where Insiders Are Buying The Common High Yield Preferred Stocks Preferreds Trading At Premiums To Liquidation Preference Preferreds Trading At Discounts To Liquidation Preference The Top 10 DividendRank'ed U.S. Stocks The Top 10 DividendRank'ed Canadian Stocks Top 25 Broker Analyst Picks of the S&P 500 Stock market game

Featured News Links

• Press releases from ACCESSWIRE  • Forget Treasuries: These 7%+ Dividends Are Much Safer  • Perfect Pullback Play with a Safe 8.4% Payout  • This 10.4% Dividend Ticks Our 2 “Must-Have” Boxes  • These Tax-Free Funds Are the Biggest Dividend Secret Going